IRCT20200927048849N3招募中3 期
Comparison of the Effectiveness of COVID-19 specific antibody in hyper-immune bovine milk & colostrum with ordinary bovine milk & colostrum on reducing the need for hospitalization and improving clinical symptoms of patients with COVID-19 that are taken care of in home.
Isfahan university0 个研究点目标入组 600 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Infected patients of COVID-19 based on positive Polymerase Chain Reaction test
- •Lack of hospitalization indication based on country protocol
- •O2 Saturation more than 93% on the first visit
- •Respiratory rate more than 24 on the first visit
- •Age more than 18 years old
- •Filling and signing of consent form
- •A maximum of 10 days have elapsed since the onset of disease symptoms
排除标准
- •Patients with immunodeficiency based on biography
- •Lactose intolerance based on biography
- •Uncontrollable vomiting
- •Using antiviral drugs
- •Failure to fill out the consent form
- •Receiving immunosuppressive drugs
研究者
相似试验
已完成
2 期
Effect of hyperimmune bovine milk & colostrum in the healing process of COVID-19 patientsCOVID-19.COVID-19, virus identifiedU07.1IRCT20200927048849N2Isfahan university40
终止
不适用
Effectiveness of the Fiocruz Vaccine ® against different variants of SARS-COV-2 in Botucatu-SPRBR-8yrrf9sniversidade Estadual Paulista Júlio de Mesquita Filho (UNESP) - Faculdade de Medicina de Botucatu (FMB)
尚未招募
不适用
Effect of recombinant erythropoietin in covid-19 patients.CTRI/2020/11/028959All India Institute Of Medical Sciences New Delhi
已完成
Unknown
Clinical Performance Verification Study of "COVID-19 Ag Rapid Saliva Test Device" for Diagnostic Aid of SARS-CoV-2 InfectioCOVID-19JPRN-UMIN000049723BIC GROUP Ltd.120
招募中
3 期
The impact of COVID-19 treatment on the type, strength and duration of antibody and cellular immune responses in SARS-CoV-2 patients in sub-Saharan AfricaAncillary Study of the ANTICOV Study:An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild / moderate cases of COVID-19Covid-19PACTR202010781639956DNDi1,000